AI Startup Speeds Disease Research With Lab in the Loop | NVIDIA Blog
Link Image

BrainStorm Therapeutics is accelerating brain disease research with AI and lab experiments using organoids.

NASDAQ:NVDA
Wall Street

2025-04-22